Compliance & Validation — Documented
HIPAA, SOC 2 Type II, ISO 27001
Komodo Health
Healthcare map platform providing real-world evidence and market intelligence for pharma commercialization.
Komodo Health has built the Healthcare Map — a longitudinal view of the complete patient journey covering over 330 million de-identified patients in the U.S. Their AI platform enables pharmaceutical companies to identify undiagnosed patients, optimize market access strategies, and generate real-world evidence across the product lifecycle.
- Headquarters
- San Francisco, United States
- Founded
- 2014
- Compliance
- HIPAA, SOC 2 Type II, ISO 27001
- Deployment options
- cloud
- Website
- https://www.komodohealth.com
- https://www.linkedin.com/company/komodo-health
Categories
AI Use Cases
- Market Access & HTA Strategy
- Patient Identification & Segmentation
- Signal Detection & Aggregate Reporting
Vendor Scorecard
100% — Complete coverage. Coverage score — how completely Atlas documents Komodo Health across 7 buyer-evaluation areas. Reflects available Atlas data, not solution quality.
Deployment & Hosting — Documented
cloud
Pricing Transparency — Documented
Annual data license + platform fee
Implementation & Onboarding — Documented
1–3 months
Organization & Role Fit — Documented
Mid-Size Biotech, Large Pharma, Top 20 Pharma, Commercial, Medical Affairs, Pharmacovigilance, R&D Leadership
Solution Scope — Documented
Adverse Event Detection, Market Access Analytics, Real-World Evidence
Company Viability — Documented
Series E, $514M raised, 500+ employees, Founded 2014
Always ask the vendor
Not captured in Atlas data — confirm directly. Excluded from the score above.
Data Rights & IP
Who owns model outputs? Is our proprietary data used to train models others can access, and where does our data reside?
Model Credibility & Explainability
Can you share validation studies or benchmarks, explain how the model reaches its conclusions, and describe how bias and drift are monitored?
Evidence & Outcomes
Intercept used Komodo's real-world data for PBC (Ocaliva) analyses
Intercept Pharmaceuticals worked with Komodo Health to apply its Healthcare Map real-world data to primary biliary cholangitis, supporting patient-journey and treatment-pattern analyses for its Ocaliva franchise.
press release (Komodo Health (Business Wire)) · 2022-11-10 — Partner: Intercept Pharmaceuticals
Questions to Ask This Vendor
- How complete is patient journey data for our target therapeutic area?
- How do you handle patient re-identification risk?
- Can we integrate Komodo data with our internal CRM?